NCT02860962View on ClinicalTrials.gov

A Trial of Dextromethorphan for Treatment of Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Major Depressive Disorder
Interventions
DRUG

Dextromethorphan Hydrobromide

Dose as a single capsule preparation formulated by the Investigational Drug Service of MUSC specifically for the purposes of this trial.

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT02860962 - A Trial of Dextromethorphan for Treatment of Major Depressive Disorder | Biotech Hunter | Biotech Hunter